LAES insider filings
SEALSQ Corp — 39 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen LAES transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 11 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings by 1 insider — 85,000 shares, $170,294 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 35,000 shares @ $2.46 ($85,936) by Enguent Jean-Pierre, filed 2026-10-07.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Enguent Jean-Pierre — Vice President, R&DSS | 3 | — | 3 legs · 85,000 sh · $170,294 | 10 |
| Feuardent Moreira Andreas — Chief Innovation Officer | 1 | — | — | 6 |
| Moreira Carlos — Chief Executive Officer, Director | 1 | — | — | 6 |
| O'Hara John Charles — Chief Financial Officer, Director | 1 | — | — | 4 |
| Verjus Nathalie Claude Odile — Company Secretary | 1 | — | — | 4 |
| Buonanno Franck Jean — Vice-President, Global Sales | 1 | — | — | 3 |
| Fergusson David Alexander — Director | 1 | — | — | 2 |
| Pellaton Eric Adrien — Director | 1 | — | — | 2 |
| Ward Peter — Director | 1 | — | — | 2 |
Recent insider filings — SEALSQ Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Verjus Nathalie Claude Odile — Company Secretary | Option exercise (M): 60,235 @ $0.01 · Tax withholding (F): 22,596 @ $1.20 · Grant/award (A): 60,235 (derivative) @ $0 · Option exercise (M): 60,235 (derivative) @ $0 | EDGAR |
| 2026-11-19 | 4 | Buonanno Franck Jean — Vice-President, Global Sales | Option exercise (M): 50,000 @ $0.01 · Grant/award (A): 50,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Option exercise (M): 160,624 @ $0.01 · Tax withholding (F): 66,631 @ $1.15 · Grant/award (A): 160,624 (derivative) @ $0 · Option exercise (M): 160,624 (derivative) @ $0 | EDGAR |
| 2026-11-18 | 4 | Feuardent Moreira Andreas — Chief Innovation Officer | Option exercise (M): 40,157 @ $0.01 · Tax withholding (F): 12,309 @ $1.15 · Grant/award (A): 40,157 (derivative) @ $0 · Option exercise (M): 40,157 (derivative) @ $0 · Grant/award (A): 40,155 (derivative) @ $0 · Grant/award (A): 40,155 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | Moreira Carlos — Chief Executive Officer, Director | Option exercise (M): 1,606,226 @ $0.01 · Tax withholding (F): 856,514 @ $1.25 · Grant/award (A): 1,606,226 (derivative) @ $0 · Option exercise (M): 1,606,226 (derivative) @ $0 · Grant/award (A): 1,606,225 (derivative) @ $0 · Grant/award (A): 1,606,225 (derivative) @ $0 | EDGAR |
| 2026-11-03 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 15,000 @ $0.01 · Option exercise (M): 20,000 @ $0.01 · Sale (S): 35,000 @ $1.38 · Option exercise (M): 15,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-10-07 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 35,000 @ $0.01 · Sale (S): 35,000 @ $2.46 · Grant/award (A): 50,000 (derivative) @ $0 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2026-10-06 | 4 | Ward Peter — Director | Grant/award (A): 3,582 (derivative) @ $0 · Grant/award (A): 4,686 (derivative) @ $0 | EDGAR |
| 2026-10-06 | 4 | Pellaton Eric Adrien — Director | Grant/award (A): 10,747 (derivative) @ $0 · Grant/award (A): 14,063 (derivative) @ $0 | EDGAR |
| 2026-10-06 | 4 | Fergusson David Alexander — Director | Grant/award (A): 3,424 (derivative) @ $0 · Grant/award (A): 14,063 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 15,000 @ $0.01 · Sale (S): 15,000 @ $2.40 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 15,000 @ $0.01 · Sale (S): 15,000 @ $2.46 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 15,000 @ $0.01 · Sale (S): 15,000 @ $2.82 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Ward Peter — Director | Option exercise (M): 366,746 @ $0.01 · Tax withholding (F): 96,530 @ $3.07 · Option exercise (M): 13,649 (derivative) @ $0 · Option exercise (M): 353,097 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 143 @ $3.51 | EDGAR |
| 2026-06-05 | 4 | Moreira Carlos — Chief Executive Officer, Director | Sale (S): 300 @ $3.51 | EDGAR |
| 2026-06-03 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 15,000 @ $0.01 · Sale (S): 15,000 @ $3.51 · Grant/award (A): 60,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $3.69 · Sale (S): 5,582 @ $3.53 | EDGAR |
| 2026-06-03 | 4 | Moreira Carlos — Chief Executive Officer, Director | Sale (S): 10,000 @ $3.69 · Sale (S): 7,005 @ $3.53 | EDGAR |
| 2026-05-29 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 4,689 @ $3.50 · Sale (S): 10,000 @ $3.51 | EDGAR |
| 2026-05-29 | 4 | Moreira Carlos — Chief Executive Officer, Director | Sale (S): 4,139 @ $3.50 · Sale (S): 10,000 @ $3.51 | EDGAR |
| 2026-05-15 | 4 | Buonanno Franck Jean — Vice-President, Global Sales | Sale (S): 20,000 @ $2.90 | EDGAR |
| 2026-05-11 | 4 | Buonanno Franck Jean — Vice-President, Global Sales | Option exercise (M): 20,000 @ $0.01 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Sale (S): 15,000 @ $3.13 | EDGAR |
| 2026-05-04 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 15,000 @ $0.01 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $3.06 · Sale (S): 10,000 @ $2.88 · Sale (S): 5,250 @ $2.91 | EDGAR |
| 2026-04-22 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $2.79 · Sale (S): 10,000 @ $3.04 | EDGAR |
| 2026-04-17 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $2.69 · Sale (S): 10,000 @ $2.72 | EDGAR |
| 2026-04-14 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Option exercise (M): 130,500 @ $0.01 · Grant/award (A): 130,500 (derivative) @ $0 · Option exercise (M): 130,500 (derivative) @ $0 | EDGAR |
| 2026-04-09 | 4 | Enguent Jean-Pierre — Vice President, R&DSS | Option exercise (M): 15,000 @ $0.01 · Sale (S): 15,000 @ $2.20 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-04-09 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $2.14 · Sale (S): 10,000 @ $2.20 · Sale (S): 10,000 @ $2.08 | EDGAR |
| 2026-04-08 | 4 | Feuardent Moreira Andreas — Chief Innovation Officer | Option exercise (M): 10,000 @ $0.01 · Sale (S): 10,000 @ $2.31 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $2.45 · Sale (S): 10,000 @ $2.42 | EDGAR |
| 2026-04-01 | 4 | Buonanno Franck Jean — Vice-President, Global Sales | Sale (S): 10,000 @ $2.35 | EDGAR |
| 2026-03-31 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Option exercise (M): 100,000 @ $0.01 · Grant/award (A): 100,000 (derivative) @ $0 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | Buonanno Franck Jean — Vice-President, Global Sales | Option exercise (M): 15,000 @ $0.01 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $2.99 · Sale (S): 10,000 @ $2.90 · Sale (S): 10,000 @ $2.92 | EDGAR |
| 2026-03-23 | 4 | O'Hara John Charles — Chief Financial Officer, Director | Sale (S): 10,000 @ $3.02 · Sale (S): 10,000 @ $3.00 | EDGAR |
| 2026-03-19 | 4 | Verjus Nathalie Claude Odile — Company Secretary | Sale (S): 5,000 @ $3.03 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LAES returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs